Kevin Stiver
Interventional Cardiology · Columbus, OHNPI 1356502280
Payments from drug & device makers
Across 217 payments — averaging $172.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Circulation Inc$30K
- Boston Scientific$3K
- Medtronic$778
- Edwards Lifesciences$474
- Abbott$333
- Penumbra, Inc.$273
- plus $2K from 20 others
What the payments were for
- Consulting fees$10,36328%
- Speaking & faculty fees$17,65047%
- Travel & lodging$2,6837%
- Food & beverage$6,65518%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Circulation Inc | 26 | $30,146 |
| Boston Scientific | 44 | $3,162 |
| Medtronic(2 entities) | 28 | $778 |
| Edwards Lifesciences | 6 | $474 |
| Abbott | 7 | $333 |
| Penumbra, Inc. | 2 | $273 |
| Amgen | 17 | $257 |
| Abiomed | 4 | $249 |
| Johnson & Johnson | 18 | $213 |
| Teleflex LLC | 1 | $174 |
| Inari Medical, Inc. | 3 | $156 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $155 |
| Novartis | 10 | $138 |
| Jenavalve Technology, Inc. | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 7 | $106 |
| Regeneron Healthcare Solutions, Inc. | 6 | $104 |
| Merck | 5 | $87 |
| Stryker | 3 | $77 |
| AstraZeneca | 5 | $74 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Philips North America LLC | 1 | $63 |
| Cardinal Health 200 LLC | 4 | $62 |
| Biotronik Inc. | 2 | $31 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $18 |
| Chiesi USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TherOx DS2 Console$30,015
- Catheter$30,015
- Downstream Cartridge$30,015
- Watchman$1,375
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$305
- Indigo System$235
- COREVALVE EVOLUT R$225
- TURNPIKE$174
- CoreValve Evolut$162
- OPTICROSS$150
- Impella$149
- AVVIGO Guidance System$147
- GENERAL - THERAPIES$138
- IntellaTip MiFi Filter Module$135
- GENERAL VASCULAR ACCESS$133
- PORTICO$132
- WATCHMAN FLX$132
- JenaValve Pericardial TAVR System$112
How this compares
$37,350 in reported general payments places this provider in the 70th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $96,325 |
| XareltoRivaroxaban | 31 | $33,504 |
| Repatha SureclickEvolocumab | 49 | $29,242 |
| EntrestoSacubitril/Valsartan | 18 | $21,380 |
| FarxigaDapagliflozin Propanediol | 12 | $9,556 |
| Ranolazine ErRanolazine | 20 | $1,565 |
| Atorvastatin Calcium | 162 | $1,421 |
| ClopidogrelClopidogrel Bisulfate | 158 | $1,011 |
| Metoprolol Succinate | 72 | $998 |
| Carvedilol | 88 | $553 |
| Losartan Potassium | 58 | $438 |
| Amlodipine Besylate | 60 | $390 |
| Potassium Chloride | 15 | $369 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 44 | $355 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $213 | $33,50431 claims |
| NovartisEntresto | $138 | $21,38018 claims |
| AstraZenecaFarxiga | $74 | $9,55612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Columbus
- Gary AnselColumbus$3.4M
- Steven YakubovColumbus$3.2M
- Carlos Sanchez SotoColumbus$1.7M
- John CheathamColumbus$1.7M
- Mitchell SilverColumbus$1.1M
- John PhillipsColumbus$619K
- Michael JollyColumbus$427K
- Konstantinos BoudoulasColumbus$403K
- Timothy SmithColumbus$337K
- Joseph CampbellColumbus$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.